1. Home
  2. AUTL vs PLSE Comparison

AUTL vs PLSE Comparison

Compare AUTL & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUTL
  • PLSE
  • Stock Information
  • Founded
  • AUTL 2014
  • PLSE 2014
  • Country
  • AUTL United Kingdom
  • PLSE United States
  • Employees
  • AUTL N/A
  • PLSE N/A
  • Industry
  • AUTL Biotechnology: Biological Products (No Diagnostic Substances)
  • PLSE Medical/Dental Instruments
  • Sector
  • AUTL Health Care
  • PLSE Health Care
  • Exchange
  • AUTL Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • AUTL 1.1B
  • PLSE 1.0B
  • IPO Year
  • AUTL 2018
  • PLSE 2016
  • Fundamental
  • Price
  • AUTL $2.98
  • PLSE $18.32
  • Analyst Decision
  • AUTL Strong Buy
  • PLSE
  • Analyst Count
  • AUTL 3
  • PLSE 0
  • Target Price
  • AUTL $10.20
  • PLSE N/A
  • AVG Volume (30 Days)
  • AUTL 2.7M
  • PLSE 200.4K
  • Earning Date
  • AUTL 11-12-2024
  • PLSE 10-30-2024
  • Dividend Yield
  • AUTL N/A
  • PLSE N/A
  • EPS Growth
  • AUTL N/A
  • PLSE N/A
  • EPS
  • AUTL N/A
  • PLSE N/A
  • Revenue
  • AUTL $10,091,000.00
  • PLSE N/A
  • Revenue This Year
  • AUTL $816.67
  • PLSE N/A
  • Revenue Next Year
  • AUTL $374.47
  • PLSE N/A
  • P/E Ratio
  • AUTL N/A
  • PLSE N/A
  • Revenue Growth
  • AUTL 82.71
  • PLSE N/A
  • 52 Week Low
  • AUTL $2.69
  • PLSE $6.60
  • 52 Week High
  • AUTL $7.45
  • PLSE $22.69
  • Technical
  • Relative Strength Index (RSI)
  • AUTL 38.60
  • PLSE 55.85
  • Support Level
  • AUTL $2.69
  • PLSE $15.62
  • Resistance Level
  • AUTL $3.25
  • PLSE $17.20
  • Average True Range (ATR)
  • AUTL 0.33
  • PLSE 1.22
  • MACD
  • AUTL -0.04
  • PLSE 0.03
  • Stochastic Oscillator
  • AUTL 23.08
  • PLSE 59.51

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: